US Patent Issued to GUANGZHOU CELLPROTEK PHARMACEUTICAL on June 3 for "Hexokinase 2-specific inhibitors for use in acute central nervous system injury" (Chinese Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,750, issued on June 3, was assigned to GUANGZHOU CELLPROTEK PHARMACEUTICAL Co. LTD (Guangdong, China).

"Hexokinase 2-specific inhibitors for use in acute central nervous system injury" was invented by Guangmei Yan (Guangdong, China), Wei Yin (Guangdong, China), Yuan Li (Guangdong, China), Bingzheng Lu (Guangdong, China) and Longxiang Sheng (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are applications of a hexokinase 2-specific inhibitor in preparing a medicament for preventing and treating acute central nervous system injury."

The patent was filed on Jan. 11, 2023, under Application No. 18/095,660.

*For further informat...